Nuveen’s Spruce Biosciences SPRB Stock Holding History

Nuveen’s Portfolio SPRB Stock Details SPRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$121K	Buy	+2,501	New	+$127K	﹤0.01%	3955
2022 Q2	–	Sell	-155	Closed	-$24K	–	3521
2022 Q1	$24K	Hold	155	–	–	﹤0.01%	3292
2021 Q4	$29K	Sell	155 -152	-50%	-$45.2K	﹤0.01%	3311
2021 Q3	$164K	Sell	307 -88	-22%	-$55.2K	﹤0.01%	3290
2021 Q2	$332K	Buy	395 +243	+160%	+$259K	﹤0.01%	3214
2021 Q1	$190K	Sell	152 -150	-50%	-$230K	﹤0.01%	3246
2020 Q4	$551K	Buy	+302	New	+$501K	﹤0.01%	3023

Other funds holding SPRB

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13B AUM 35.88% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Nuveen's SPRB Position: Q3 2026 in Review

Nuveen opened a new position in Spruce Biosciences (SPRB) in Q3 2026: 2,501 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #3955 among its holdings. This is a return to the name: Nuveen previously reported a position in SPRB as recently as Q1 2022.

Nuveen first reported a position in SPRB in Q4 2020 and has held it in 7 quarters since. The position peaked at $551K in Q4 2020. 22 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

Nuveen held 2,501 shares of Spruce Biosciences worth $121K as of Q3 2026.
Spruce Biosciences was a new Nuveen position in Q3 2026.
Spruce Biosciences made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #3955 holding.
Nuveen first reported a position in Spruce Biosciences in Q4 2020 and has held it in 7 quarters since.
Nuveen's Spruce Biosciences position peaked at $551K in Q4 2020.
22 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.